Skip to Main Content

Advertisement

Skip Nav Destination

Nonclinical characterization of bexmarilimab, a Clever-1-targeting antibody for supporting immune defense against cancers

Mol Cancer Ther molcanther.0840.2021.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal